ArticleCurrent medicinal chemistry2026
Gene Expression Variations Induced by Sevoflurane in Glia and Glioma Cells and the Role of EPHA3 in Sevoflurane's Anti-Glioma Effect.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionsSevoflurane, a commonly used anesthetic in surgery, can produce anesthetic effects such as sedation and muscle relaxation upon inhalation, which may lead to postoperative cognitive dysfunction. However, the molecular mechanism by which sevoflurane affects nervous system diseases like glioma remains unclear.
methodsIn this study, we analyzed high-throughput single-cell transcriptome data of sevoflurane treatment and identified immune cells that play crucial roles in biological processes such as the immunoinflammatory response and the maintenance of the blood- -brain barrier. A total of 11,244 genes and their variations were obtained by analyzing the cell development trajectory. Additionally, 10 key genes affected by sevoflurane were manually retrieved, and their protein-protein interaction network was constructed. The Chinese Glioma Genome Atlas (CGGA) dataset was utilized for survival analysis.
resultsThis article reveals that sevoflurane can generate anesthetic effects through signaling pathways such as the immunoinflammatory response, neuronal differentiation, and the maintenance of the blood-brain barrier, all of which have implications for organ injury and protection. Meanwhile, genes that play a key role in these immune pathways, such as the DAAM2 and EPHA3 genes, are significantly associated with the survival of glioma patients. This association implies that sevoflurane's influence on these genes might potentially affect postoperative cognitive dysfunction and the overall outcome of organ-organ interactions during and after surgery. Moreover, the experimental results demonstrated that sevoflurane inhibits the invasion and migration of glioma cells by suppressing the expression of EPHA3.
conclusionThe discovery of this new target may pave the way for identifying causative gene regulation events and emphasize personalized treatments for nervous system diseases.
Indexed as
Identifiers
39931981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.